search
Back to results

Use of the LOK® Robotic Gait Trainer in the Early Rehabilitation of Children After an Acquired Brain Injury (ABI)

Primary Purpose

Injury, Brain

Status
Unknown status
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Lokomat
Sponsored by
Holland Bloorview Kids Rehabilitation Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional device feasibility trial for Injury, Brain focused on measuring physical therapy, gait, pediatric rehabilitation, gross motor function, participation

Eligibility Criteria

5 Years - 18 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Be an inpatient or daypatient in the Brain Injury Rehabilitation program at Holland Bloorview Kids Rehabilitation Hospital with moderate or severe ABI
  • Be Gross Motor Function Classification System-equivalent III or IV with primary gait goals
  • Have any limb distribution of involvement (spasticity or hypotonicity). The physiotherapist (PT) and Lokomat (LOK) sessions (both about 45-minutes in length) will employ a motor learning strategies approach.
  • Have a femur length at least 21 cm (to fit robotic legs) and height no greater than 6' 3" to fit LOK frame
  • Be no more than 12 months post-ABI (i.e., still active rehab stage), and
  • Be expected by clinical team (confirmed by child's physician) to have at least 8 more weeks of inpatient or daypatient rehab
  • Be able to follow Gross Motor Function Measure instructions and participate in > 45 minutes of active PT (as judged by the child's PT)
  • Be able to reliably signal pain and discomfort using verbal or nonverbal signals (as assessed at the screening assessment) for LOK operation safety reasons.

Exclusion Criteria:

  • A seizure in the last 12 months,
  • Inability to tolerate full weightbearing
  • A knee flexion contracture > 20 degrees, knee valgus >40 degrees, hip subluxation > 40% migration percentage
  • Excessive tone or ataxic or dyskinetic movements may be an exclusion (would be determined at LOK set-up confirmation visit).

Sites / Locations

  • Holland Bloorview Kids Rehabilitation HospitalRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Lokomat

Arm Description

16 sessions total. Provided by study PT twice weekly for 8 weeks.

Outcomes

Primary Outcome Measures

Gross Motor Function Measure (GMFM-66)
Change from baseline in motor function on Gross Motor Function Measure (GMFM-66) at week 8
Canadian Occupational Performance Measure (COPM)
Change from baseline in targeted goal abilities and satisfaction with performance as measured by the Canadian Occupational Performance Measure at week 8

Secondary Outcome Measures

Goal Attainment Scale (GAS)
Change from baseline in targeted goal abilities as measured by Goal Attainment Scaling (GAS) at week 8. Three to five individualized walking-based activity/participation goals are set with child/parent/treating PT at baseline. Goal achievement level (score of -2 to+2) evaluated by treating PT with child/parent input at post-intervention assessment. GAS outcome (achievement) is measured by a standardized T-score that is a summary score(calculated from individual goal -2 to +2 scores) for the child's set of goals . Goal accomplishment at the targeted level (averaged across the goal set) is reflected by a T score = 50.0 + 5 with range of scores from ~ 25 to 85.
Gait speed (10 minute fastest walk test )
Change from baseline in Gait Speed (10 minute fastest walk test) at week 8
Observational Gait Scale
Change from baseline in Gait quality as measured on an observational gait scale at week 8. Gait pattern evaluated via an observational 25-item scale (Total score /100 with higher scores indicating better pattern) that was constructed and validated in cerebral palsy by CoPI Wright at the research facility. Rating is from video of child's walking along a 7 metre distance.
The Pediatric Evaluation of Disability Inventory (PEDI-CAT)
Change from baseline in PEDI-CAT at week 8.
Movement Ability Self-efficacy Questionnaire (MASQ)
Change from baseline in MASQ at week 8
Gait Kinematics (measured on the GaitRite evaluation system)
Change from baseline in gait kinematics as measured on the GaitRite evaluation system at week 8

Full Information

First Posted
May 3, 2018
Last Updated
September 18, 2018
Sponsor
Holland Bloorview Kids Rehabilitation Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT03678064
Brief Title
Use of the LOK® Robotic Gait Trainer in the Early Rehabilitation of Children After an Acquired Brain Injury (ABI)
Official Title
Use of the LOK® Robotic Gait Trainer in the Early Rehabilitation of Children After an Acquired Brain Injury (ABI): A Feasibility Study - Part III
Study Type
Interventional

2. Study Status

Record Verification Date
June 2018
Overall Recruitment Status
Unknown status
Study Start Date
June 5, 2018 (Actual)
Primary Completion Date
March 2019 (Anticipated)
Study Completion Date
March 2019 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Holland Bloorview Kids Rehabilitation Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
After an acquired brain injury (ABI), children often require extensive physiotherapy (PT) to help them relearn to walk. There is promising evidence in pediatric neuro-motor conditions of the possibility for brain activation pattern changes in response to repetitive, task-oriented functional gait training. Robotic-assisted gait training devices such as the Lokomat (LOK) allow this type of intensive walking retraining. The aim of this study is to assess the safety, feasibility and outcome possibilities linked to a LOK intervention given as 2 of the child's 4 PT weekly sessions over 8-weeks in the early stages of rehabilitation after an ABI.
Detailed Description
This is Phase 3 of our three- year ABI Lokomat study . Phase 1 was conducted in 2016-2017 and was a single-group pre- and post-test feasibility study of the Lokomat in pediatric ABI inpatients and daypatients in which we enrolled 9 patient participants. The co-primary outcome measures for this first phase were the Gross Motor Function Measure (GMFM), Canadian Occupational Performance Measure (COPM) . Other measures of function (PEDI-CAT), gait (6 minute walk test and Timed up and GO) and individualized goals (Goal Attainment Scaling) were included. Study feasibility was evaluated via indicators such as enrollment, number of sessions completed, drop out rate, and adverse events. Phase 2 was conducted in 2017-2018 using the same core outcome set, and added a qualitative study component with child and parent and physiotherapist interviews for their perspective on the Lokomat experience and associated outcomes. The investigators enrolled 6 patient participants (quantitative and qualitative) and their caregivers (qualitative). Phase 3 will aim to enroll 6 to 8 more children to strengthen effect size estimates for the GMFM and COPM in particular (proposed co-primary outcome measures for future randomized controlled trial). The investigators will also add in an observational gait scale to measure potential changes in gait pattern/quality which investigators have noted in the first 2 years of the study, and pilot a measure of children's self-efficacy that the investigators will design for this study. Finally, the investigators will take a close look at motor learning strategies (MLS) used by the PTs in both LOK and PT sessions using the validated Motor Learning Strategies Rating Instrument (MLSRI) to begin to get a profile of comparative MLS use in gym-based PT and LOK sessions. The investigators will continue to study feasibility and add to the data from the first 2 phases the ABI LOK project.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Injury, Brain
Keywords
physical therapy, gait, pediatric rehabilitation, gross motor function, participation

7. Study Design

Primary Purpose
Device Feasibility
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
7 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Lokomat
Arm Type
Experimental
Arm Description
16 sessions total. Provided by study PT twice weekly for 8 weeks.
Intervention Type
Device
Intervention Name(s)
Lokomat
Intervention Description
16 sessions total. Provided by study PT twice weekly for a period of 8 weeks
Primary Outcome Measure Information:
Title
Gross Motor Function Measure (GMFM-66)
Description
Change from baseline in motor function on Gross Motor Function Measure (GMFM-66) at week 8
Time Frame
Baseline, 8 weeks
Title
Canadian Occupational Performance Measure (COPM)
Description
Change from baseline in targeted goal abilities and satisfaction with performance as measured by the Canadian Occupational Performance Measure at week 8
Time Frame
Baseline, 8 weeks
Secondary Outcome Measure Information:
Title
Goal Attainment Scale (GAS)
Description
Change from baseline in targeted goal abilities as measured by Goal Attainment Scaling (GAS) at week 8. Three to five individualized walking-based activity/participation goals are set with child/parent/treating PT at baseline. Goal achievement level (score of -2 to+2) evaluated by treating PT with child/parent input at post-intervention assessment. GAS outcome (achievement) is measured by a standardized T-score that is a summary score(calculated from individual goal -2 to +2 scores) for the child's set of goals . Goal accomplishment at the targeted level (averaged across the goal set) is reflected by a T score = 50.0 + 5 with range of scores from ~ 25 to 85.
Time Frame
Baseline, 8 weeks
Title
Gait speed (10 minute fastest walk test )
Description
Change from baseline in Gait Speed (10 minute fastest walk test) at week 8
Time Frame
Baseline, 8 weeks
Title
Observational Gait Scale
Description
Change from baseline in Gait quality as measured on an observational gait scale at week 8. Gait pattern evaluated via an observational 25-item scale (Total score /100 with higher scores indicating better pattern) that was constructed and validated in cerebral palsy by CoPI Wright at the research facility. Rating is from video of child's walking along a 7 metre distance.
Time Frame
Baseline, 8 weeks
Title
The Pediatric Evaluation of Disability Inventory (PEDI-CAT)
Description
Change from baseline in PEDI-CAT at week 8.
Time Frame
Baseline, 8 weeks
Title
Movement Ability Self-efficacy Questionnaire (MASQ)
Description
Change from baseline in MASQ at week 8
Time Frame
Baseline, week 8
Title
Gait Kinematics (measured on the GaitRite evaluation system)
Description
Change from baseline in gait kinematics as measured on the GaitRite evaluation system at week 8
Time Frame
Baseline, week 8
Other Pre-specified Outcome Measures:
Title
Feasibility indicator: Recruitment Rate
Description
Recruitment rate (%) as measured by: # of participants enrolled / # of participants screened and eligible
Time Frame
Monthly over 12 months through study completion
Title
Feasibility indicator: Retention Rate
Description
Retention rate (%) as measured by: # of participants completing both baseline and follow-up assessment / total # of participants
Time Frame
Monthly over 12 months through study completion
Title
Feasibility indicator: Protocol Adherence
Description
Protocol adherence (%) as measured by: Number of sessions completed / 16 possible sessions
Time Frame
Monthly over 12 months through study completion
Title
Motor Learning Strategies Rating Instrument (MLSRI)
Description
Compare motor learning strategy (MLS) use in LOK and PT to explore how LOK use may affect motor skill acquisition post-ABI.
Time Frame
Week 2-3, Week 6-7

10. Eligibility

Sex
All
Minimum Age & Unit of Time
5 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Be an inpatient or daypatient in the Brain Injury Rehabilitation program at Holland Bloorview Kids Rehabilitation Hospital with moderate or severe ABI Be Gross Motor Function Classification System-equivalent III or IV with primary gait goals Have any limb distribution of involvement (spasticity or hypotonicity). The physiotherapist (PT) and Lokomat (LOK) sessions (both about 45-minutes in length) will employ a motor learning strategies approach. Have a femur length at least 21 cm (to fit robotic legs) and height no greater than 6' 3" to fit LOK frame Be no more than 12 months post-ABI (i.e., still active rehab stage), and Be expected by clinical team (confirmed by child's physician) to have at least 8 more weeks of inpatient or daypatient rehab Be able to follow Gross Motor Function Measure instructions and participate in > 45 minutes of active PT (as judged by the child's PT) Be able to reliably signal pain and discomfort using verbal or nonverbal signals (as assessed at the screening assessment) for LOK operation safety reasons. Exclusion Criteria: A seizure in the last 12 months, Inability to tolerate full weightbearing A knee flexion contracture > 20 degrees, knee valgus >40 degrees, hip subluxation > 40% migration percentage Excessive tone or ataxic or dyskinetic movements may be an exclusion (would be determined at LOK set-up confirmation visit).
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Ryan Hung, MD, MSc
Phone
4167536019
Email
rhung@hollandbloorview.ca
First Name & Middle Initial & Last Name or Official Title & Degree
Virginia Wright, PT, PhD
Phone
4164256220
Ext
3824
Email
vwright@hollandbloorview.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ryan Hung, MD, MSc
Organizational Affiliation
Holland Bloorview Kids Rehabilitation Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Virginia Wright, PT, PhD
Organizational Affiliation
Holland Bloorview Kids Rehabilitation Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Holland Bloorview Kids Rehabilitation Hospital
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M4G2X3
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ryan Hung, MD
Phone
4167536019
Email
rhung@hollandbloorview.ca
First Name & Middle Initial & Last Name & Degree
Virginia Wright, PhD
Phone
4164256220
Ext
3824
Email
vwright@hollandbloorview.ca

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
25915458
Citation
Beretta E, Romei M, Molteni E, Avantaggiato P, Strazzer S. Combined robotic-aided gait training and physical therapy improve functional abilities and hip kinematics during gait in children and adolescents with acquired brain injury. Brain Inj. 2015;29(7-8):955-62. doi: 10.3109/02699052.2015.1005130. Epub 2015 Apr 27.
Results Reference
background
PubMed Identifier
21415229
Citation
Levac D, Missiuna C, Wishart L, Dematteo C, Wright V. Documenting the content of physical therapy for children with acquired brain injury: development and validation of the motor learning strategy rating instrument. Phys Ther. 2011 May;91(5):689-99. doi: 10.2522/ptj.20100415. Epub 2011 Mar 17.
Results Reference
background
PubMed Identifier
22574628
Citation
Kamath T, Pfeifer M, Banerjee-Guenette P, Hunter T, Ito J, Salbach NM, Wright V, Levac D. Reliability of the motor learning strategy rating instrument for children and youth with acquired brain injury. Phys Occup Ther Pediatr. 2012 Aug;32(3):288-305. doi: 10.3109/01942638.2012.672551. Epub 2012 May 11.
Results Reference
background

Learn more about this trial

Use of the LOK® Robotic Gait Trainer in the Early Rehabilitation of Children After an Acquired Brain Injury (ABI)

We'll reach out to this number within 24 hrs